TRELLIS BIOSCIENCE
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
TRELLIS BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1998-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.trellisbio.com
Total Employee:
51+
Status:
Active
Contact:
(650)616-1100
Email Addresses:
[email protected]
Total Funding:
28.58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Universal Analytics Euro Microsoft Azure DNS PHP OpenResty
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Trellis Bioscience
Pac-Link
Pac-Link investment in Series B - Trellis Bioscience
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Trellis Bioscience
Easton Capital
Easton Capital investment in Series B - Trellis Bioscience
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Trellis Bioscience
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2006-05-24 | Promedior | Trellis Bioscience investment in Series A - Promedior | 14 M USD |
Official Site Inspections
http://www.trellisbio.com Semrush global rank: 1.7 M Semrush visits lastest month: 14.14 K
- Host name: 209.17.116.160
- IP address: 209.17.116.160
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258